Top Markets
Coin of the day
Cypherpunk Technologies Inc. Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH
Pozycja w akcjach #19166
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Cena akcji
$1.62
Ostatnia synchronizacja: 2026-08-25
Kapitalizacja rynkowa
$172.47M
Zmiana (1 dzień)
-3.57%
Zmiana (1 rok)
446.74%
Kraj
US
Handel Cypherpunk Technologies Inc. (CYPH)

Kategoria

Historia ceny akcji dla Cypherpunk Technologies Inc. (CYPH)
Najwyższa cena zamknięcia: $0.94 dnia 2026-08-01

Najniższa cena zamknięcia: $75.65 dnia 2017-01-01
Historia cen akcji firmy Cypherpunk Technologies Inc. od 2017 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -31.92%
2025 -58.69%
2024 -5.41%
2023 -33.87%
2022 -82.32%
2021 38.52%
2020 121.83%
2019 -68.29%
2018 -56.56%
2017 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$770.45 7.08%
CH